Clene Provides Update On Its NIH-Funded Expanded Access Program For CNM-Au8® In ALS (ACT-EAP)

Related Keywords

National Institutes Of Health ,Maryland ,United States ,Utah ,Salt Lake City ,Kevin Gardner ,Jinsya Andrews ,David Schull ,Austin Rynders ,Peter Wallach ,Rob Etherington ,Ignacio Guerrero Ros ,Securities Exchange ,Nasdaq ,Twitter ,Access To Critical Therapies Expanded Program ,Clene Nanomedicine Inc ,Russo Partners ,Columbia University ,National Institute Of Neurological Disorders ,Drug Administration ,Linkedin ,Clene Inc ,National Institutes ,Accelerating Access ,Critical Therapies Expanded Access Program ,National Institute ,Neurological Disorders ,Clinical Operations ,Medical Affairs ,Principal Investigator ,Chief Financial Officer ,Compassionate Use ,President Biden ,Critical Therapies ,Clene Nanomedicine ,Securities Exchange Act ,Securities Act ,Annual Report ,Quarterly Reports ,